 | • レポートコード：QYR2104Z1069 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がんスクリーニング技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器ベース検査、プラットフォームベース検査）、用途別市場規模（肺がん検診、乳がん検診、前立腺がん検診、結腸直腸がん検診、血液がん検診、肝がん検診、膵臓がん検診、皮膚がん検診、子宮頸がん検診、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がんスクリーニング技術の市場動向 ・企業の競争状況、市場シェア ・がんスクリーニング技術の種類別市場規模（機器ベース検査、プラットフォームベース検査） ・がんスクリーニング技術の用途別市場規模（肺がん検診、乳がん検診、前立腺がん検診、結腸直腸がん検診、血液がん検診、肝がん検診、膵臓がん検診、皮膚がん検診、子宮頸がん検診、その他） ・がんスクリーニング技術の北米市場規模2016-2027（アメリカ、カナダ） ・がんスクリーニング技術のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がんスクリーニング技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がんスクリーニング技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・がんスクリーニング技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、BD、Siemens Healthineers、GE Healthcare、F. Hoffmann-La Roche、Olympus Corporation、FUJIFILM Corporation、Agilent Technologies、Eiken Chemical、Hitachi Chemical (Kyowa Medex)、Clinical Genomics Pty Ltd (Quest Diagnostics)、Sysmex、QIAGEN、R-Biopharm、Immunostics） ・結論 |
Market Analysis and Insights: Global Cancer Screening Technology Market
The global Cancer Screening Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Screening Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Screening Technology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Screening Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Screening Technology market.
Global Cancer Screening Technology Scope and Market Size
Cancer Screening Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Screening Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Instrument-based Inspection
Platform-based Inspection
Segment by Application
Lung Cancer Screening
Breast Cancer Screening
Prostate Cancer Screening
Colorectal Cancer Screening
Blood Cancer Screening
Liver Cancer Screening
Pancreatic Cancer Screening
Skin Cancer Screening
Cervical Cancer Screening
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
BD
Siemens Healthineers
GE Healthcare
F. Hoffmann-La Roche
Olympus Corporation
FUJIFILM Corporation
Agilent Technologies
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instrument-based Inspection
1.2.3 Platform-based Inspection
1.3 Market by Application
1.3.1 Global Cancer Screening Technology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lung Cancer Screening
1.3.3 Breast Cancer Screening
1.3.4 Prostate Cancer Screening
1.3.5 Colorectal Cancer Screening
1.3.6 Blood Cancer Screening
1.3.7 Liver Cancer Screening
1.3.8 Pancreatic Cancer Screening
1.3.9 Skin Cancer Screening
1.3.10 Cervical Cancer Screening
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Technology Market Perspective (2016-2027)
2.2 Cancer Screening Technology Growth Trends by Regions
2.2.1 Cancer Screening Technology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Screening Technology Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Screening Technology Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Screening Technology Industry Dynamic
2.3.1 Cancer Screening Technology Market Trends
2.3.2 Cancer Screening Technology Market Drivers
2.3.3 Cancer Screening Technology Market Challenges
2.3.4 Cancer Screening Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Technology Players by Revenue
3.1.1 Global Top Cancer Screening Technology Players by Revenue (2016-2021)
3.1.2 Global Cancer Screening Technology Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Screening Technology Revenue
3.4 Global Cancer Screening Technology Market Concentration Ratio
3.4.1 Global Cancer Screening Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Technology Revenue in 2020
3.5 Cancer Screening Technology Key Players Head office and Area Served
3.6 Key Players Cancer Screening Technology Product Solution and Service
3.7 Date of Enter into Cancer Screening Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Technology Breakdown Data by Type
4.1 Global Cancer Screening Technology Historic Market Size by Type (2016-2021)
4.2 Global Cancer Screening Technology Forecasted Market Size by Type (2022-2027)
5 Cancer Screening Technology Breakdown Data by Application
5.1 Global Cancer Screening Technology Historic Market Size by Application (2016-2021)
5.2 Global Cancer Screening Technology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Screening Technology Market Size (2016-2027)
6.2 North America Cancer Screening Technology Market Size by Type
6.2.1 North America Cancer Screening Technology Market Size by Type (2016-2021)
6.2.2 North America Cancer Screening Technology Market Size by Type (2022-2027)
6.2.3 North America Cancer Screening Technology Market Size by Type (2016-2027)
6.3 North America Cancer Screening Technology Market Size by Application
6.3.1 North America Cancer Screening Technology Market Size by Application (2016-2021)
6.3.2 North America Cancer Screening Technology Market Size by Application (2022-2027)
6.3.3 North America Cancer Screening Technology Market Size by Application (2016-2027)
6.4 North America Cancer Screening Technology Market Size by Country
6.4.1 North America Cancer Screening Technology Market Size by Country (2016-2021)
6.4.2 North America Cancer Screening Technology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Screening Technology Market Size (2016-2027)
7.2 Europe Cancer Screening Technology Market Size by Type
7.2.1 Europe Cancer Screening Technology Market Size by Type (2016-2021)
7.2.2 Europe Cancer Screening Technology Market Size by Type (2022-2027)
7.2.3 Europe Cancer Screening Technology Market Size by Type (2016-2027)
7.3 Europe Cancer Screening Technology Market Size by Application
7.3.1 Europe Cancer Screening Technology Market Size by Application (2016-2021)
7.3.2 Europe Cancer Screening Technology Market Size by Application (2022-2027)
7.3.3 Europe Cancer Screening Technology Market Size by Application (2016-2027)
7.4 Europe Cancer Screening Technology Market Size by Country
7.4.1 Europe Cancer Screening Technology Market Size by Country (2016-2021)
7.4.2 Europe Cancer Screening Technology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Technology Market Size (2016-2027)
8.2 Asia-Pacific Cancer Screening Technology Market Size by Type
8.2.1 Asia-Pacific Cancer Screening Technology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Screening Technology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Screening Technology Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Screening Technology Market Size by Application
8.3.1 Asia-Pacific Cancer Screening Technology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Screening Technology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Screening Technology Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Screening Technology Market Size by Region
8.4.1 Asia-Pacific Cancer Screening Technology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Screening Technology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Screening Technology Market Size (2016-2027)
9.2 Latin America Cancer Screening Technology Market Size by Type
9.2.1 Latin America Cancer Screening Technology Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Screening Technology Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Screening Technology Market Size by Type (2016-2027)
9.3 Latin America Cancer Screening Technology Market Size by Application
9.3.1 Latin America Cancer Screening Technology Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Screening Technology Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Screening Technology Market Size by Application (2016-2027)
9.4 Latin America Cancer Screening Technology Market Size by Country
9.4.1 Latin America Cancer Screening Technology Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Screening Technology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Technology Market Size (2016-2027)
10.2 Middle East & Africa Cancer Screening Technology Market Size by Type
10.2.1 Middle East & Africa Cancer Screening Technology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Screening Technology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Screening Technology Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Screening Technology Market Size by Application
10.3.1 Middle East & Africa Cancer Screening Technology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Screening Technology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Screening Technology Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Screening Technology Market Size by Country
10.4.1 Middle East & Africa Cancer Screening Technology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Screening Technology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cancer Screening Technology Introduction
11.1.4 Abbott Revenue in Cancer Screening Technology Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Cancer Screening Technology Introduction
11.2.4 BD Revenue in Cancer Screening Technology Business (2016-2021)
11.2.5 BD Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Cancer Screening Technology Introduction
11.3.4 Siemens Healthineers Revenue in Cancer Screening Technology Business (2016-2021)
11.3.5 Siemens Healthineers Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Cancer Screening Technology Introduction
11.4.4 GE Healthcare Revenue in Cancer Screening Technology Business (2016-2021)
11.4.5 GE Healthcare Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Cancer Screening Technology Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Olympus Corporation
11.6.1 Olympus Corporation Company Details
11.6.2 Olympus Corporation Business Overview
11.6.3 Olympus Corporation Cancer Screening Technology Introduction
11.6.4 Olympus Corporation Revenue in Cancer Screening Technology Business (2016-2021)
11.6.5 Olympus Corporation Recent Development
11.7 FUJIFILM Corporation
11.7.1 FUJIFILM Corporation Company Details
11.7.2 FUJIFILM Corporation Business Overview
11.7.3 FUJIFILM Corporation Cancer Screening Technology Introduction
11.7.4 FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2016-2021)
11.7.5 FUJIFILM Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cancer Screening Technology Introduction
11.8.4 Agilent Technologies Revenue in Cancer Screening Technology Business (2016-2021)
11.8.5 Agilent Technologies Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Details
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Cancer Screening Technology Introduction
11.9.4 Eiken Chemical Revenue in Cancer Screening Technology Business (2016-2021)
11.9.5 Eiken Chemical Recent Development
11.10 Hitachi Chemical (Kyowa Medex)
11.10.1 Hitachi Chemical (Kyowa Medex) Company Details
11.10.2 Hitachi Chemical (Kyowa Medex) Business Overview
11.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Introduction
11.10.4 Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2016-2021)
11.10.5 Hitachi Chemical (Kyowa Medex) Recent Development
11.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
11.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
11.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
11.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Introduction
11.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2016-2021)
11.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex Cancer Screening Technology Introduction
11.12.4 Sysmex Revenue in Cancer Screening Technology Business (2016-2021)
11.12.5 Sysmex Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Technology Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Technology Business (2016-2021)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Technology Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Technology Business (2016-2021)
11.14.5 R-Biopharm Recent Development
11.15 Immunostics
11.15.1 Immunostics Company Details
11.15.2 Immunostics Business Overview
11.15.3 Immunostics Cancer Screening Technology Introduction
11.15.4 Immunostics Revenue in Cancer Screening Technology Business (2016-2021)
11.15.5 Immunostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Screening Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instrument-based Inspection
Table 3. Key Players of Platform-based Inspection
Table 4. Global Cancer Screening Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cancer Screening Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Screening Technology Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cancer Screening Technology Market Share by Regions (2016-2021)
Table 8. Global Cancer Screening Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cancer Screening Technology Market Share by Regions (2022-2027)
Table 10. Cancer Screening Technology Market Trends
Table 11. Cancer Screening Technology Market Drivers
Table 12. Cancer Screening Technology Market Challenges
Table 13. Cancer Screening Technology Market Restraints
Table 14. Global Cancer Screening Technology Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cancer Screening Technology Market Share by Players (2016-2021)
Table 16. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Screening Technology as of 2020)
Table 17. Ranking of Global Top Cancer Screening Technology Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cancer Screening Technology Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Screening Technology Product Solution and Service
Table 21. Date of Enter into Cancer Screening Technology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Screening Technology Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cancer Screening Technology Revenue Market Share by Type (2016-2021)
Table 25. Global Cancer Screening Technology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cancer Screening Technology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cancer Screening Technology Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cancer Screening Technology Revenue Market Share by Application (2016-2021)
Table 29. Global Cancer Screening Technology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cancer Screening Technology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cancer Screening Technology Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cancer Screening Technology Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cancer Screening Technology Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cancer Screening Technology Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Screening Technology Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cancer Screening Technology Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cancer Screening Technology Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cancer Screening Technology Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cancer Screening Technology Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cancer Screening Technology Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cancer Screening Technology Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cancer Screening Technology Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cancer Screening Technology Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cancer Screening Technology Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Screening Technology Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Screening Technology Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Screening Technology Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cancer Screening Technology Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cancer Screening Technology Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cancer Screening Technology Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Screening Technology Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cancer Screening Technology Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Screening Technology Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cancer Screening Technology Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cancer Screening Technology Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cancer Screening Technology Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Screening Technology Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Screening Technology Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Screening Technology Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cancer Screening Technology Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Cancer Screening Technology Product
Table 64. Abbott Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Cancer Screening Technology Product
Table 69. BD Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 70. BD Recent Development
Table 71. Siemens Healthineers Company Details
Table 72. Siemens Healthineers Business Overview
Table 73. Siemens Healthineers Cancer Screening Technology Product
Table 74. Siemens Healthineers Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 75. Siemens Healthineers Recent Development
Table 76. GE Healthcare Company Details
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Cancer Screening Technology Product
Table 79. GE Healthcare Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Cancer Screening Technology Product
Table 84. F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Olympus Corporation Company Details
Table 87. Olympus Corporation Business Overview
Table 88. Olympus Corporation Cancer Screening Technology Product
Table 89. Olympus Corporation Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 90. Olympus Corporation Recent Development
Table 91. FUJIFILM Corporation Company Details
Table 92. FUJIFILM Corporation Business Overview
Table 93. FUJIFILM Corporation Cancer Screening Technology Product
Table 94. FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 95. FUJIFILM Corporation Recent Development
Table 96. Agilent Technologies Company Details
Table 97. Agilent Technologies Business Overview
Table 98. Agilent Technologies Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 99. Agilent Technologies Recent Development
Table 100. Eiken Chemical Company Details
Table 101. Eiken Chemical Business Overview
Table 102. Eiken Chemical Cancer Screening Technology Product
Table 103. Eiken Chemical Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 104. Eiken Chemical Recent Development
Table 105. Hitachi Chemical (Kyowa Medex) Company Details
Table 106. Hitachi Chemical (Kyowa Medex) Business Overview
Table 107. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Product
Table 108. Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 109. Hitachi Chemical (Kyowa Medex) Recent Development
Table 110. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
Table 111. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
Table 112. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Product
Table 113. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 114. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
Table 115. Sysmex Company Details
Table 116. Sysmex Business Overview
Table 117. Sysmex Cancer Screening Technology Product
Table 118. Sysmex Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 119. Sysmex Recent Development
Table 120. QIAGEN Company Details
Table 121. QIAGEN Business Overview
Table 122. QIAGEN Cancer Screening Technology Product
Table 123. QIAGEN Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 124. QIAGEN Recent Development
Table 125. R-Biopharm Company Details
Table 126. R-Biopharm Business Overview
Table 127. R-Biopharm Cancer Screening Technology Product
Table 128. R-Biopharm Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 129. R-Biopharm Recent Development
Table 130. Immunostics Company Details
Table 131. Immunostics Business Overview
Table 132. Immunostics Cancer Screening Technology Product
Table 133. Immunostics Revenue in Cancer Screening Technology Business (2016-2021) & (US$ Million)
Table 134. Immunostics Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Screening Technology Market Share by Type: 2020 VS 2027
Figure 2. Instrument-based Inspection Features
Figure 3. Platform-based Inspection Features
Figure 4. Global Cancer Screening Technology Market Share by Application: 2020 VS 2027
Figure 5. Lung Cancer Screening Case Studies
Figure 6. Breast Cancer Screening Case Studies
Figure 7. Prostate Cancer Screening Case Studies
Figure 8. Colorectal Cancer Screening Case Studies
Figure 9. Blood Cancer Screening Case Studies
Figure 10. Liver Cancer Screening Case Studies
Figure 11. Pancreatic Cancer Screening Case Studies
Figure 12. Skin Cancer Screening Case Studies
Figure 13. Cervical Cancer Screening Case Studies
Figure 14. Other Case Studies
Figure 15. Cancer Screening Technology Report Years Considered
Figure 16. Global Cancer Screening Technology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Cancer Screening Technology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Cancer Screening Technology Market Share by Regions: 2020 VS 2027
Figure 19. Global Cancer Screening Technology Market Share by Regions (2022-2027)
Figure 20. Global Cancer Screening Technology Market Share by Players in 2020
Figure 21. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Screening Technology as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Cancer Screening Technology Revenue in 2020
Figure 23. Global Cancer Screening Technology Revenue Market Share by Type (2016-2021)
Figure 24. Global Cancer Screening Technology Revenue Market Share by Type (2022-2027)
Figure 25. North America Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Cancer Screening Technology Market Share by Type (2016-2027)
Figure 27. North America Cancer Screening Technology Market Share by Application (2016-2027)
Figure 28. North America Cancer Screening Technology Market Share by Country (2016-2027)
Figure 29. United States Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cancer Screening Technology Market Share by Type (2016-2027)
Figure 33. Europe Cancer Screening Technology Market Share by Application (2016-2027)
Figure 34. Europe Cancer Screening Technology Market Share by Country (2016-2027)
Figure 35. Germany Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cancer Screening Technology Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Cancer Screening Technology Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Cancer Screening Technology Market Share by Region (2016-2027)
Figure 45. China Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cancer Screening Technology Market Share by Type (2016-2027)
Figure 53. Latin America Cancer Screening Technology Market Share by Application (2016-2027)
Figure 54. Latin America Cancer Screening Technology Market Share by Country (2016-2027)
Figure 55. Mexico Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cancer Screening Technology Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Cancer Screening Technology Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Cancer Screening Technology Market Share by Country (2016-2027)
Figure 61. Turkey Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Cancer Screening Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Abbott Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 65. BD Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 66. Siemens Healthineers Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 67. GE Healthcare Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 68. F. Hoffmann-La Roche Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 69. Olympus Corporation Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 70. FUJIFILM Corporation Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 71. Agilent Technologies Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 72. Eiken Chemical Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 73. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 74. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 75. Sysmex Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 76. QIAGEN Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 77. R-Biopharm Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 78. Immunostics Revenue Growth Rate in Cancer Screening Technology Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の子宮頸がんスクリーニング市場規模・現状・予測（2021年-2027年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…- 世界のがん検診/スクリーニング市場規模・現状・予測（2021年-2027年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…
- 世界の乳がんスクリーニング検査市場規模・現状・予測（2021年-2027年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- 世界のDNA腸がんスクリーニングキット市場規模・現状・予測（2021年-2027年） It is a non-invasive genetic test for bowel cancer which examines the DNA code for 11 genes known to cause an increased risk of bowel cancer. It is performed on a blood sample and if possible it is more informative to test a relative who has had bowel cancer first. Market Analysis and Insights: Glob…
- 世界の前立腺がんスクリーニング市場規模・現状・予測（2021年-2027年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…